S Jamal Mustafa Selected Research

S Jamal Mustafa Research Topics

Disease

12	Inflammation (Inflammations) 01/2020 - 01/2002
10	Asthma (Bronchial Asthma) 01/2020 - 01/2002
5	Atherosclerosis 01/2021 - 07/2011
5	Ischemia 08/2011 - 09/2002
4	Hypertension (High Blood Pressure) 01/2021 - 02/2018
4	Hyperemia 01/2021 - 05/2013
3	Pneumonia (Pneumonitis) 01/2020 - 01/2002
3	Hypoxia (Hypoxemia) 08/2013 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Myocardial Infarction 01/2019 - 12/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 07/2011
2	Body Weight (Weight, Body) 04/2014 - 08/2003
2	Respiratory Hypersensitivity 07/2010 - 04/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Vascular System Injuries 01/2020
1	Vascular Ring 02/2018
1	Myocarditis (Carditis) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Reperfusion Injury 08/2013
1	Endotoxemia 07/2013
1	Hyperlipidemias (Hyperlipidemia) 07/2011
1	Airway Obstruction (Choking) 01/2009
1	Chest Pain (Chest Pains) 11/2004
1	Ataxia (Dyssynergia) 12/2002

Drug/Important Bio-Agent (IBA)

24	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2002
14	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 01/2002
5	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2003
5	AllergensIBA 07/2010 - 01/2002
4	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 01/2020 - 04/2005
4	KATP ChannelsIBA 10/2014 - 09/2002
3	AerosolsIBA 01/2020 - 05/2008
2	uridine adenosine tetraphosphateIBA 01/2019 - 12/2017
2	Apolipoproteins E (ApoE)IBA 12/2017 - 04/2014
2	regadenoson FDA Link 01/2016 - 07/2011
2	Purinergic P1 Receptor AntagonistsIBA 03/2007 - 10/2005
2	Histamine (Histamine Dihydrochloride)FDA Link 12/2006 - 10/2005
2	Ethanol (Ethyl Alcohol)IBA 08/2003 - 12/2002
1	ectoATPaseIBA 01/2020
1	OvalbuminIBA 01/2020
1	Terpenes (Terpenoids)IBA 01/2020
1	Methacholine Chloride (Methacholine)FDA Link 01/2020
1	LimoneneIBA 01/2020
1	EnzymesIBA 01/2020
1	PD 123319IBA 06/2019
1	Arg-Pro-Leu-Lys-Pro-TrpIBA 06/2019
1	Losartan (Cozaar)FDA LinkGeneric 06/2019
1	Angiotensin IIIBA 06/2019
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 02/2018
1	Apelin ReceptorsIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2016
1	LipopolysaccharidesIBA 07/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2013
1	CytokinesIBA 05/2008
1	3- ethyl- 1- propyl- 8- (1- (3- trifluoromethylbenzyl)- 1H- pyrazol- 4- yl)- 3,7- dihydropurine- 2,6- dioneIBA 03/2007
1	Adenosine Monophosphate (AMP)IBA 03/2007
1	Adenosine A1 ReceptorIBA 12/2006
1	montelukast (Singulair)FDA Link 12/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2006
1	Messenger RNA (mRNA)IBA 10/2006
1	purineIBA 10/2005
1	p-Methoxy-N-methylphenethylamineIBA 04/2005
1	N(6)-(2-endo-norbornyl)adenosineIBA 03/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2003
1	Dronabinol (THC)FDA LinkGeneric 12/2002
1	Psychotropic Drugs (Psychoactive Drugs)IBA 12/2002
1	OligodeoxyribonucleotidesIBA 12/2002
1	CannabinoidsIBA 12/2002
1	Glyburide (Glibenclamide)FDA LinkGeneric 09/2002
1	1,3-dipropyl-8-cyclopentylxanthineIBA 09/2002
1	chelerythrineIBA 09/2002
1	S-methylisothiopseudouroniumIBA 09/2002
1	Theophylline (Theon)FDA LinkGeneric 01/2002

Therapy/Procedure

1	Baths 02/2018
1	Therapeutics 10/2005